Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial

Maya Hites , Clement R Massonnaud , Simon Jamard , Francois Goehringer , Francois Danion , Jean Reignier , Nathalie de Castro , Denis Garot , Eva Larranaga Lapique , Karine Lacombe , Violaine Tolsma , Emmanuel Faure , Denis Malvy (1, 2) , Therese Staub , Johan Courjon , France Cazenave-Roblot , Anne Ma Dyrhol Riise , Paul Leturnier , Guillaume Martin-Blondel , Claire Roger , Karolina Akinosoglou , Vincent Le Moing , Lionel Piroth , Pierre Sellier , Xavier Lescure , Marius Troseid , Philippe Clevenbergh , Olav Dalgard , Sebastien Gallien , Marie Gousseff , Paul Loubet , Fanny Vardon-Bounes , Clotilde Visee , Leila Belkhir , Elisabeth Botelho-Nevers , Andre Cabie , Anastasia Kotanidou , Fanny Lanternier , Elisabeth Rouveix-Nordon , Susana Silva , Guillaume Thiery , Pascal Poignard , Guislaine Carcelain , Alpha Diallo , Noemie Mercier , Vida Terzic , Maude Bouscambert-Duchamp , Alexandre Gaymard , Mary-Anne Trabaud , Gregory Destras , Laurence Josset , Drifa Belhadi , Nicolas Billard , Jeremie Guedj , Thi-Hong-Lien Han , Sandrine Couffin-Cadiergues , Aline Dechanet , Christelle Delmas , Helene Esperou , Claire Fougerou-Leurent , Soizic Le Mestre , Anabelle Metois , Marion Noret , Isabelle Bally , Sebastian Dergan-Dylon , Sarah Tubiana , Ouifiya Kalif , Nathalie Bergaud , Benjamin Leveau , Joe Eustace , Richard Greil , Edit Hajdu , Monika Halanova , Jose-Artur Paiva , Anna Piekarska , Jesus Rodriguez Bano , Kristian Tonby , Milan Trojanek , Sotirios Tsiodras , Serhat Unal , Charles Burdet , Dominique Costagliola , Yazdan Yazdanpanah , Nathan Peiffer-Smadja , France Mentre , Florence Ader , Group Discovery Study

1 BPH - Bordeaux population health
2 GHiGS - Global Health in the Global South

Domaines: Santé publique et épidémiologie

Maya Hites, Clement R Massonnaud, Simon Jamard, Francois Goehringer, Francois Danion, et al.. Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial. Journal of Infection, 2024, 88 (3), pp.106120. ⟨10.1016/j.jinf.2024.106120⟩. ⟨hal-04509759⟩